Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2026-03-09 @ 6:16 PM
Study NCT ID:
NCT00250302
Status:
COMPLETED
Last Update Posted:
2011-04-28
First Post:
2005-11-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures
Sponsor:
Hadassah Medical Organization
Organization:
Study Overview
Official Title:
Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures
Status:
COMPLETED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Mesenchymal stem cells are found in bone marrow, and have the ability to differentiate into different tissue types. The primary objective of the study is to examine the safety of using such cells to treat patients suffering from distal tibial shaft fractures. The cells will be isolated from the patient's bone marrow, loaded onto a carrier and implanted locally at the fracture site.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: